Lack of sustained regression of c-MYC-induced mammary adenocarcinomas following brief or prolonged MYC inactivation

Cancer Cell

Volumn 6, Issue 6, 2004, Pages 577-586

  Boxer, Robert B ^a,b   Jang, Joanne W ^a,b   Sintasath, Louis ^a,b   Chodosh, Lewis A ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BREAST ADENOCARCINOMA; CANCER CELL; CANCER GROWTH; CANCER RECURRENCE; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION; GENE INACTIVATION; GENE MUTATION; MOUSE; NONHUMAN; NORTHERN BLOTTING; ONCOGENE C MYC; PRIORITY JOURNAL; TARSAL TUNNEL SYNDROME; TRANSGENIC MOUSE; TUMOR REGRESSION;

ANIMALIA; MUS MUSCULUS;

EID: 10944258521     PISSN: 15356108     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccr.2004.10.013     Document Type: Article

References (21)

1. Chin L., Tam A., Pomerantz J., Wong M., Holash J., Bardeesy N., Shen Q., O'Hagan R., Pantginis J., Zhou H., et al. Essential role for oncogenic Ras in tumour maintenance. Nature. 400:1999;468-472
2. D'Cruz C.M., Gunther E.J., Boxer R.B., Hartman J.L., Sintasath L., Moody S.E., Cox J.D., Ha S.I., Belka G.K., Golant A., et al. c-MYC induces mammary tumorigenesis by means of a preferred pathway involving spontaneous Kras2 mutations. Nat. Med. 7:2001;235-239
3. Druker B.J., Talpaz M., Resta D.J., Peng B., Buchdunger E., Ford J.M., Lydon N.B., Kantarjian H., Capdeville R., Ohno-Jones S., Sawyers C.L. Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia. N. Engl. J. Med. 344:2001;1031-1037
4. Felsher D.W., Bishop J.M. Reversible tumorigenesis by MYC in hematopoietic lineages. Mol. Cell. 4:1999;199-207. a
5. Felsher D.W., Bishop J.M. Transient excess of MYC activity can elicit genomic instability and tumorigenesis. Proc. Natl. Acad. Sci. USA. 96:1999;3940-3944. b
6. Fisher G.H., Wellen S.L., Klimstra D., Lenczowski J.M., Tichelaar J.W., Lizak M.J., Whitsett J.A., Koretsky A., Varmus H.E. Induction and apoptotic regression of lung adenocarcinomas by regulation of a K-Ras transgene in the presence and absence of tumor suppressor genes. Genes Dev. 15:2001;3249-3262
7. Gunther E.J., Belka G.K., Wertheim G.B., Wang J., Hartman J.L., Boxer R.B., Chodosh L.A. A novel doxycycline-inducible system for the transgenic analysis of mammary gland biology. FASEB J. 16:2002;283-292
8. Gunther E.J., Moody S.E., Belka G.K., Hahn K.T., Innocent N., Dugan K.D., Cardiff R.D., Chodosh L.A. Impact of p53 loss on reversal and recurrence of conditional Wnt-induced tumorigenesis. Genes Dev. 17:2003;488-501
9. Huettner C.S., Zhang P., Van Etten R.A., Tenen D.G. Reversibility of acute B-cell leukaemia induced by BCR-ABL1. Nat. Genet. 24:2000;57-60
10. Jain M., Arvanitis C., Chu K., Dewey W., Leonhardt E., Trinh M., Sundberg C.D., Bishop J.M., Felsher D.W. Sustained loss of a neoplastic phenotype by brief inactivation of MYC. Science. 297:2002;102-104
11. Kantarjian H., Sawyers C., Hochhaus A., Guilhot F., Schiffer C., Gambacorti-Passerini C., Niederwieser D., Resta D., Capdeville R., Zoellner U., et al. Hematologic and cytogenetic responses to imatinib mesylate in chronic myelogenous leukemia. N. Engl. J. Med. 346:2002;645-652
12. Karlsson A., Deb-Basu D., Cherry A., Turner S., Ford J., Felsher D.W. Defective double-strand DNA break repair and chromosomal translocations by MYC overexpression. Proc. Natl. Acad. Sci. USA. 100:2003;9974-9979
13. Liao D.J., Dickson R.B. c-Myc in breast cancer. Endocr. Relat. Cancer. 7:2000;143-164
14. Moody S.E., Sarkisian C.J., Hahn K.T., Gunther E.J., Pickup S., Dugan K.D., Innocent N., Cardiff R.D., Schnall M.D., Chodosh L.A. Conditional activation of Neu in the mammary epithelium of transgenic mice results in reversible pulmonary metastasis. Cancer Cell. 2:2002;451-461
15. Pelengaris S., Khan M. The c-MYC oncoprotein as a treatment target in cancer and other disorders of cell growth. Expert Opin. Ther. Targets. 7:2003;623-642. a
16. Pelengaris S., Littlewood T., Khan M., Elia G., Evan G. Reversible activation of c-Myc in skin. induction of a complex neoplastic phenotype by a single oncogenic lesion Mol. Cell. 3:1999;565-577
17. Pelengaris S., Khan M. The many faces of c-MYC. Arch. Biochem. Biophys. 416:2003;129-136. b
18. Pelengaris S., Khan M., Evan G.I. Suppression of Myc-induced apoptosis in beta cells exposes multiple oncogenic properties of Myc and triggers carcinogenic progression. Cell. 109:2002;321-334
19. Rajan J.V., Wang M., Marquis S.T., Chodosh L.A. Brca2 is coordinately regulated with Brca1 during proliferation and differentiation in mammary epithelial cells. Proc. Natl. Acad. Sci. USA. 93:1996;13078-13083
20. Vindelov L.L. Flow microfluorometric analysis of nuclear DNA in cells from solid tumors and cell suspensions. A new method for rapid isolation and straining of nuclei. Virchows Arch. B Cell Pathol. 24:1977;227-242
21. Weinstein I.B. Cancer. Addiction to oncogenes-the Achilles heal of cancer. Science. 297:2002;63-64